The medtech firm strengthens its full-stack remote cardiac monitoring platform, achieves 11x revenue growth, and advances its global expansion plans
The SELECT-SWITCH study, first head-to-head Phase 3b/4 trial, compared switching to Rinvoq versus switching to another TNF inhibitor
He has published more than 100 research papers in several prestigious national and international journals
The new solution, built on patented blockchain technology, dynamically adapts to patients' behaviour patterns to make clinical encounters more effective
Investment in technology and people and a meaningful industry-academia partnership can fuel the growth of the Indian biopharma sector
The company intends to file an IND submission by the end of this year and begin clinical studies in 2027
The company’s shares of confidence were underlined by an upgraded 2026 outlook, with Merck now expecting annual net sales of up to €21.4 billion and EBITDA pre of as much as €6.1 billion
The standout story remains Wegovy, particularly its new oral formulation
The Pharmaceuticals portfolio and pipeline are more promising than perhaps ever before
Germany will be the first launch market
Subscribe To Our Newsletter & Stay Updated
